Shaoxing Xingxin New Material Co.,Ltd (SHE:001358)
21.64
+1.37 (6.76%)
Jul 27, 2026, 1:55 PM CST
SHE:001358 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 486.28 | 474.56 | 468.14 | 630.24 | 774.47 | 506.44 |
Revenue Growth | 4.38% | 1.37% | -25.72% | -18.62% | 52.92% | 35.60% |
Gross Profit Gross Profit Growth | 133.98 | 125.07 | 145.33 | 218.1 | 310.2 | 191.95 |
Operating Income Operating Income Growth | 39.84 | 35.85 | 68.86 | 149.81 | 233.67 | 135.21 |
Net Income Net Income Growth | 52.34 | 48.31 | 81.15 | 141.58 | 208.9 | 115.54 |
Earnings Per Share EPS Growth | 0.42 | 0.39 | 0.66 | 1.53 | 2.26 | 1.25 |
EPS Growth | -32.04% | -40.91% | -56.86% | -32.43% | 81.14% | 124.38% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Piperazine Series Piperazine Series Growth | 373.87 | 405.91 | 548.55 | 672.03 | 438.49 |
Amide Series Amide Series Growth | 49.39 | 32.43 | 25.21 | 20.18 | 30.21 |
Others Others Growth | 51.3 | 29.8 | 56.49 | 82.27 | 38.98 |
Total Total Growth | 474.56 | 468.14 | 630.24 | 774.47 | 507.68 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 763.68 | 749.58 | 926.24 | 1,063 | 151.03 | 79.83 |
Total Debt Total Debt Growth | 19.12 | 27.94 | 6.59 | 44.91 | 28.01 | 64.9 |
Net Cash (Debt) Net Cash Growth | 744.56 | 721.64 | 919.65 | 1,019 | 123.02 | 14.93 |
Net Cash Growth | -18.07% | -21.53% | -9.71% | 727.94% | 724.21% | 590.61% |
Net Cash Per Share Net Cash Per Share Growth | 5.99 | 5.83 | 7.48 | 11.01 | 1.33 | 0.16 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 70.86 | 59.93 | 92.43 | 112.33 | 105.92 | 56.91 |
Capital Expenditures CapEx Growth | -139.93 | -150.09 | -50.25 | -26.84 | -9.28 | -9.74 |
Free Cash Flow Free Cash Flow Growth | -69.08 | -90.15 | 42.18 | 85.49 | 96.63 | 47.17 |
Free Cash Flow Growth | - | - | -50.66% | -11.53% | 104.87% | 118.64% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 27.55% | 26.35% | 31.05% | 34.61% | 40.05% | 37.90% |
Operating Margin | 8.19% | 7.56% | 14.71% | 23.77% | 30.17% | 26.70% |
Pretax Margin | 11.43% | 10.61% | 19.86% | 24.65% | 31.11% | 26.22% |
Profit Margin | 10.76% | 10.18% | 17.34% | 22.46% | 26.97% | 22.81% |
FCF Margin | -14.21% | -19.00% | 9.01% | 13.56% | 12.48% | 9.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.250 | 0.250 | 0.500 | 1.200 |
Dividend Per Share Growth | -50.00% | -50.00% | -58.33% | - |
Dividend Yield | 1.23% | 0.98% | 2.31% | 3.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 48.14 | 64.55 | 33.47 | 29.84 | - | - |
P/FCF Ratio | - | - | 64.40 | 49.41 | - | - |
PS Ratio | 5.04 | 6.57 | 5.80 | 6.70 | - | - |